IDARUBICIN

作品数：7被引量：9H指数：2
导出分析报告
相关领域：医药卫生更多>>
相关作者：陈菲莉柳约坚董慧娟王诗韵徐兵更多>>
相关机构：南方医科大学南方医院兰州大学更多>>
相关期刊：《Acta Pharmacologica Sinica》《World Journal of Gastroenterology》《Journal of Hainan Medical University》《Chinese Medical Journal》更多>>
相关基金：国家自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-7
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome:A prospective multicenter clinical cohort study
《Chinese Medical Journal》2024年第9期1115-1117,共3页Yigeng Cao Mingyang Wang Fuxu Wang Wenwen Guo Yueshen Ma Xiaoyun Li Yi He Aiming Pang Rongli Zhang Weihua Zhai Xin Chen Qiaoling Ma Jialin Wei Donglin Yang Yong Huang Dan Feng Jia Liu Xin Gao Shupeng Wen Wen Wang Tao Wang Ying Li Xiaosheng Fang Yingchun Li Xiaohan Zhang Yun Cai Yongqi Wang Weijie Cao Runqing Lu Sizhou Feng Rong Guo Yuewen Fu Xin Du Zhuogang Liu Xin Wang Ling Wang Liangming Ma Chuanfang Liu Xuejun Zhang Mingzhe Han Erlie Jiang 
supported by grants from the Tianjin Health Science and Technology Project(No.TJWJ2022MS001);Clinical research project of Tianjin Society of Hematology and Regenerative Medicine(No.2022 TSHRM08004);Key Project of Tianjin Natural Science Foundation(No.20JCZDJC00410);CAMS Innovation Fund for Medical Sciences(No.2021-I2M-1-073);Haihe Laboratory of Cell Ecosystem Innovation Fund(No.22HHXBSS00034);National Natural Science Foundation of China(Nos.82070192,8230012348,and 82170217)
To the Editor:Allogeneic hemopoietic stem cell transplantation(allo-HSCT)represents the only long-term survival treatment choice for patients with myelodysplastic syndromes(MDS)and MDS/myeloproliferative neoplasm(MPN)...
关键词：REGIMEN myelo PATIENTS 
Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway被引量：1
《Acta Pharmacologica Sinica》2023年第11期2296-2306,共11页Han-lin Wang Jia-nan Li Wei-juan Kan Gao-ya Xu Guang-hao Luo Ning Song Wen-biao Wu Bo Feng Jing-feng Fu Yu-tong Tu Min-min Liu Ran Xu Yu-bo Zhou Gang Wei Jia Li 
supported by National Natural Science Foundation of China(81821005);Guangdong High-level New R&D Institute(2019B090904008);Guangdong High-level Innovative Research Institute(2021B0909050003);Science and Technology Commission of Shanghai Municipality(18431907100 and 19430750100).
Current therapy for acute myeloid leukemia (AML) is largely hindered by the development of drug resistance of commonly used chemotherapy drugs, including cytarabine, daunorubicin, and idarubicin. In this study, we inv...
关键词：acute myeloid leukemia CYTARABINE DAUNORUBICIN IDARUBICIN drug resistant multi-omics AUTOPHAGY chloroquine phosphate 
PARP-1 inhibitors enhance the chemosensitivity of leukemia cells by attenuating NF-κB pathway activity and DNA damage response induced by Idarubicin被引量：1
《Acta Biochimica et Biophysica Sinica》2022年第1期91-98,共8页Bo Ke Anna Li Huan Fu Chunfang Kong Tingting Liu Qingqing Zhu Yue Zhang Zixia Zhang Chen Chen Chenghao Jin 
This work was supported by the grants from the National Natural Science Foundation of China(No.81560026);Science and Technology Project of Health and Family Planning Commission of Jiangxi Province of China(No.20181005);Science and Technology Research Project of Education Department of Jiangxi Province of China(No.GJJ200267);the Science Fund for Young Scholars of Jiangxi Province of China(No.20171BAB215031).
Idarubicin(IDA),an anthracycline antineoplastic drug,is commonly used in the treatment of acute myeloid leukemia(AML)with reasonable response rates and clinical benefits.However,some patients still relapse,or do not r...
关键词：PARP-1 inhibitor NF-кB pathway LEUKEMIA CHEMOSENSITIVITY DNA damage response 
Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma被引量：3
《World Journal of Gastroenterology》2020年第3期324-334,共11页Gael Stephane Roth Yann Teyssier Melodie Abousalihac Arnaud Seigneurin Julien Ghelfi Christian Sengel Thomas Decaens 
BACKGROUND Liver cancer is the fifth most common cancer and the second cause of cancerrelated deaths worldwide.Transarterial chemoembolization(TACE)is the best treatment of intermediate hepatocellular carcinoma(HCC).D...
关键词：Hepatocellular carcinoma Transarterial chemoembolization IDARUBICIN DOXORUBICIN Intermediate stage 
Different influence of Arac combined with idarubicin and with daunorubicin on malignant molecule expression of acute myelocytic leukemia
《Journal of Hainan Medical University》2018年第5期27-30,共4页Abudourexiti Nuerbiya Tuerhong Weinila Yimingniyazi Nueramina Palerdan Aisha 
Objective:To study the different influence of idarubicin + Arac (IA) therapy and daunorubicin + Arac (DA) therapy on malignant molecule expression of acute myelocytic leukemia. Methods: A total of 56 patients who were...
关键词：Acute myelocytic LEUKEMIA IDARUBICIN DAUNORUBICIN ARAC MALIGNANT MOLECULE 
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stemcell-transplantation in patients with high-risk acute leukemia被引量：4
《Acta Pharmacologica Sinica》2009年第10期1471-1478,共8页Qiu-bai LI Lei LI Yong YOU Zhi-chao CHEN Ling-hui XIA Ping ZOU 
Aim： To analyze the results of idarubicin （IDA）- versus etoposide （VP16）-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation （alIo-SCT） for high-risk acute leuke...
关键词：high-risk acute leukemia allogeneic stem cell transplantation intensified conditioning regimen IDARUBICIN ETOPOSIDE 
抗癌药 依达比星(Idarubicin)
《国外医药（合成药．生化药．制剂分册）》1992年第3期179-180,共2页徐积恩 
异名 Zavedos,Idamycin 化学名 4-去甲氧基-柔红霉素药效分类抗癌药开发单位 (英)Farmitalia Carlo Erba公司上市厂商 (英)Farmitalia公司 1990年在英国上市药理本品的蒽环结构上第4位没有甲氧基,因而亲脂性比柔红霉素强,细胞的吸收速...
关键词：抗癌药 依达比星 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部